Over a week ago |
Conference/Events
|
Retail & Luxury… Retail & Luxury Analyst Chen, along with Andrew Stanleick, President & CEO of The Beauty Health Company, discuss HydraFacial's growth opportunities and regional trends and the future of influencer and new media and advertising formats on an Analyst/Industry conference call to be held on June 23 at 1 pm. ShowHide Related Items >><< - 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 06/22/22 Jefferies
- Beauty Health estimates raised at Jefferies after consumer conference
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 06/17/22
- Sell these stocks now, proven algorithm says
- 05/27/22
- Sell these stocks now, proven algorithm says
- 05/13/22
- Proven algorithm says sell these stocks now
- 02/23/22
- What You Missed On Wall Street On Wednesday
- 02/15/22
- Beauth Health Company call buyer realizes 50% same-day gains
- 01/28/22
- Beauth Health Company put volume heavy and directionally bearish
|
Conference/Events
|
Retail & Luxury… Retail & Luxury Analyst Chen, along with Andrew Stanleick, President & CEO of The Beauty Health Company, discuss HydraFacial's growth opportunities and regional trends and the future of influencer and new media and advertising formats on an Analyst/Industry conference call to be held on June 23 at 1 pm. ShowHide Related Items >><< - 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 06/22/22 Jefferies
- Beauty Health estimates raised at Jefferies after consumer conference
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 06/17/22
- Sell these stocks now, proven algorithm says
- 05/27/22
- Sell these stocks now, proven algorithm says
- 05/13/22
- Proven algorithm says sell these stocks now
- 02/23/22
- What You Missed On Wall Street On Wednesday
- 02/15/22
- Beauth Health Company call buyer realizes 50% same-day gains
- 01/28/22
- Beauth Health Company put volume heavy and directionally bearish
|
Conference/Events
|
Retail & Luxury… Retail & Luxury Analyst Chen, along with Andrew Stanleick, President & CEO of The Beauty Health Company, discuss HydraFacial's growth opportunities and regional trends and the future of influencer and new media and advertising formats on an Analyst/Industry conference call to be held on June 23 at 1 pm. ShowHide Related Items >><< - 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 06/22/22 Jefferies
- Beauty Health estimates raised at Jefferies after consumer conference
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 06/17/22
- Sell these stocks now, proven algorithm says
- 05/27/22
- Sell these stocks now, proven algorithm says
- 05/13/22
- Proven algorithm says sell these stocks now
- 02/23/22
- What You Missed On Wall Street On Wednesday
- 02/15/22
- Beauth Health Company call buyer realizes 50% same-day gains
- 01/28/22
- Beauth Health Company put volume heavy and directionally bearish
|
Recommendations
|
After having hosted… After having hosted Beauty Health executives at the firm's annual Nantucket Consumer Conference, Jefferies analyst Stephanie Wissink said she came away from the meetings with greater confidence in a double-digit percentage revenue growth run rate and ample inventory to support execution. The analyst, who raised her revenue and EBITDA estimates, said management's tone was "consistently confident." She keeps a Buy rating and $24 price target on Beauty Health shares. ShowHide Related Items >><< - 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 06/17/22
- Sell these stocks now, proven algorithm says
- 05/27/22
- Sell these stocks now, proven algorithm says
- 05/13/22
- Proven algorithm says sell these stocks now
- 02/23/22
- What You Missed On Wall Street On Wednesday
- 02/15/22
- Beauth Health Company call buyer realizes 50% same-day gains
- 01/28/22
- Beauth Health Company put volume heavy and directionally bearish
|
Conference/Events
|
Consumer Conference to be… Consumer Conference to be held in Nantucket, MA on June 20-22. ShowHide Related Items >><< - 05/10/22
- Xponential Fitness in franchise pact in Mexico for three brands
- 04/21/22
- Xponential Fitness enters collaboration with Lululemon, MIRROR
- 04/05/22
- Xponential Fitness falls -8.5%
- 04/05/22
- Xponential Fitness falls -8.2%
- 05/23/22
- Transcat 'well positioned for profitable growth' in FY23, beyond
- 02/01/22
- Transcat sees Q4 Service revenue growth in high teens
- 01/03/22
- Transcat buys privately-held Tangent Labs for $9M
- 02/10/22
- Tucows approves $40M stock buyback program
- 01/07/22
- Ting Internet to be initial anchor tenant of Colorado Spring Utilities' network
- 06/15/22
- TrueBlue's Cooper: Beharelle's resignation in the best interests of the company
- 06/15/22
- TrueBlue names Chairman Steven Cooper as CEO
- 06/15/22
- TrueBlue announces resignation of CEO Patrick Beharelle, effective June 14
- 06/15/22
- TrueBlue investigation found Beharelle's behaviors violated code of conduct
- 03/23/22
- Skillz announces multiyear partnership with UFC
- 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 03/21/22
- Scholastic appoints Cristina Juvier as CPO
- 05/24/22
- Splash Beverage signs distribution agreement with Buck Distributing
- 05/04/22
- Splash Beverage's TapouT to be offered in Bashas' Family of Stores
- 04/27/22
- Splash Beverage extends distribution into upper midwest
- 04/19/22
- Splash Beverage appoints Ron Wall as CFO
- 06/02/22
- Landec completes $3.2M Curation Foods sale
- 05/10/22
- Lemonade trading resumes
- 05/10/22
- Lemonade trading halted, volatility trading pause
- 05/09/22
- Lemonade up 4% after Q1 reports
- 02/01/22
- Metromile shareholders approve merger agreement with Lemonade
- 05/19/22
- EBET announces agreement with Captain Up
- 05/04/22
- Esports Technologies changes name to EBET
- 04/19/22
- Esports Technologies announces agreement with Incentive Games
- 02/23/22
- Esports Technologies files quantum computing patent
- 05/31/22
- Nasdaq confirms continued listing of Eargo stock
- 05/13/22
- Eargo receives Nasdaq non-compliance letter
- 04/29/22
- Eargo sees Q1 gross systems shipped 5,770
- 04/29/22
- Eargo enters civil settlement agreement with U.S. DOJ
- 05/18/22
- Denbury, Nutrien enter agreement for transportation and storage of CO2
- 05/05/22
- Denbury backs previous 2022 production guidance
- 05/05/22
- Denbury announces $250M share repurchase program
- 03/16/22
- Denbury announces new agreements in Louisiana's industrial corridor
- 05/17/22
- Check Point to partner with Provision-ISR
- 04/27/22
- Check Point CFO 'hopes' supply chain constraints are temporary
- 04/05/22
- Pax8, Check Point enter agreement for cloud-based email security solutions
- 03/02/22
- Check Point launches unified go-to-market organization
- 05/11/22
- Check-Cap initiates trial of C-Scan at Mayo Clinic in Rochester Minnesota
- 02/07/22
- Check-Cap announces FDA approval of amended IDE application for C-Scan study
- 12/23/21
- Check-Cap receives Nasdaq minimum bid price notification
- 06/10/22
- CDW announces addition of two new strategy, marketing executives
- 05/02/22
- TricorBraun appoints Scott Beamer as CFO
- 04/08/22
- Entegris COO Todd Edlund to retire from the company
- 03/03/22
- CMC Materials shareholders approve merger with Entegris
- 02/15/22
- CMC Materials reports 'favorable' conclusion in patent dispute with DuPont
- 06/09/22
- Best Inc. regains NYSE compliance
- 05/10/22
- Best Inc. announces plans to implement ADS ratio change
- 04/21/22
- Li Auto, KE Holdings among new additions to SEC HFCAA provisional list
- 01/18/22
- Best Inc. receives noncompliance notification from NYSE
- 06/07/22
- Biodesix obtains Medicare coverage for Nodify CDT lung nodule test
- 06/03/22
- Biodesix announces research agreement with top U.S. cancer center
- 04/11/22
- Biodesix director Strobeck buys $1M in company shares
- 03/29/22
- Biodesix announces publication of data from GeneStrat NGS test studies
- 05/19/22
- Banner Corp. says shareholders approved all proposals at annual meeting
- 03/04/22
- Banner Corp. announces Copeland, Walsh appointed to board of directors
- 12/22/21
- Banner announces 1.7M share repurchase agreement, 5% of its common stock
- 06/06/22
- Absolute Software announces new partnerships with ISVs 'leveraging' APaaS
- 03/07/22
- Absolute Software CFO Steven Gatoff departs, Ron Fior named interim CFO
- 05/11/22 BMO Capital
- Absolute Software price target lowered to C$12 from C$14 at BMO Capital
- 05/11/22 Canaccord
- Absolute Software price target lowered to $17 from $22 at Canaccord
- 02/09/22 BMO Capital
- Absolute Software price target lowered to C$14 from C$18.50 at BMO Capital
- 02/09/22 TD Securities
- TD Securities upgrades Absolute Software to Buy after 'another' beat and raise
- 06/17/22 Stephens
- Stephens upgrades Banner to Overweight as Street mismodels rate sensitivity
- 06/17/22 Stephens
- Banner Corp. upgraded to Overweight from Equal Weight at Stephens
- 01/24/22 Raymond James
- Banner Corp. price target raised to $72 from $68 at Raymond James
- 09/07/21 DA Davidson
- Banner Corp. downgraded to Neutral from Buy at DA Davidson
- 05/05/22 Evercore ISI
- CDW removed from 'TAP Outperform' list at Evercore ISI
- 04/18/22 Evercore ISI
- CDW added to 'TAP Outperform' list at Evercore ISI
- 04/14/22 Stifel
- CDW upgraded to Buy at Stifel following recent pullback
- 04/14/22 Stifel
- CDW upgraded to Buy from Hold at Stifel
- 06/01/22 Stephens
- Digi International initiated with an Overweight at Stephens
- 02/03/22 Canaccord
- Digi International price target raised to $30 from $28 at Canaccord
- 11/11/21 Roth Capital
- Digi International price target raised to $33 from $28 at Roth Capital
- 11/11/21 Canaccord
- Digi International price target raised to $28 from $25 at Canaccord
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 06/13/22 Jefferies
- Jefferies names five top picks in lifestyle and growth platforms
- 03/14/22 Evercore ISI
- Evercore ISI starts Xponential Fitness at Outperform with $34 price target
- 03/14/22 Evercore ISI
- Xponential Fitness initiated with an Outperform at Evercore ISI
- 03/14/22 Baird
- Xponential Fitness price target raised to $28 from $26 at Baird
- 04/07/22 CL King
- CMC Materials downgraded to Neutral from Buy at CL King
- 04/07/22 CL King
- CMC Materials downgraded to Neutral from Buy at CL King
- 02/04/22 Mizuho
- CMC Materials downgraded to Neutral from Buy at Mizuho
- 12/17/21 Citi
- CMC Materials upgraded to Neutral after buyout at Citi
- 05/24/22 Citi
- California Resources, Denbury may be takeout targets, says Citi
- 05/10/22 Citi
- Denbury initiated with a Buy at Citi
- 05/05/22 Stifel
- Denbury price target raised to $129 from $126 at Stifel
- 04/26/22 KeyBanc
- KeyBanc says Axios report positive for Plug Power, other fuel cell names
- 04/06/22 Barrington
- Landec downgraded to Market Perform from Outperform at Barrington
- 09/30/21 Barrington
- Landec price target lowered to $12 from $14 at Barrington
- 05/23/22 Citi
- Skillz downgraded to Neutral from Buy at Citi
- 03/01/22 Citi
- Skillz price target lowered to $5 from $9 at Citi
- 02/24/22 Stifel
- Skillz price target lowered to $3.50 from $16 at Stifel
- 02/24/22 Wedbush
- Skillz price target lowered to $7.50 from $25 at Wedbush
- 06/02/22 H.C. Wainwright
- Transcat price target lowered to $85 from $105 at H.C. Wainwright
- 05/26/22 Roth Capital
- Transcat price target lowered to $80 from $97 at Roth Capital
- 05/25/22 Craig-Hallum
- Transcat price target lowered to $81 from $94 at Craig-Hallum
- 02/03/22 Craig-Hallum
- Pullback in Transcat shares creates buying opportunity, says Craig-Hallum
- 05/26/22 BMO Capital
- TrueBlue downgraded to Market Perform from Outperform at BMO Capital
- 04/11/22 Sidoti
- TrueBlue reinstated with a Buy at Sidoti
- 10/26/21 Baird
- TrueBlue price target raised to $35 from $31 at Baird
- 04/25/22 EF Hutton
- Splash Beverage initiated with a Buy at EF Hutton
- 02/07/22 Needham
- Needham starts Esports Technologies at Buy on esports betting opportunity
- 02/07/22 Needham
- Esports Technologies initiated with a Buy at Needham
- 06/13/22 Canaccord
- Biodesix's Medicare coverage a meaningful milestone, says Canaccord
- 05/12/22 Canaccord
- Biodesix price target lowered to $7 from $10 at Canaccord
- 04/20/22 Cowen
- Biodesix initiated with an Outperform at Cowen
- 04/18/22 BTIG
- Biodesix price target lowered to $10 from $17 at BTIG
- 05/23/22 Jefferies
- Check Point price target lowered to $130 from $145 at Jefferies
- 04/28/22 Barclays
- Check Point price target lowered to $145 from $160 at Barclays
- 04/28/22 Credit Suisse
- Check Point price target raised to $115 from $105 at Credit Suisse
- 04/28/22 Wells Fargo
- Check Point price target lowered to $130 from $144 at Wells Fargo
- 02/07/22
- Check-Cap upgraded to Buy from Neutral at Dawson James
- 09/23/21
- Fly Intel: Top five analyst downgrades
- 09/23/21 William Blair
- William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
- 09/23/21 Wells Fargo
- Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
- 09/23/21 William Blair
- Eargo downgraded to Market Perform from Outperform at William Blair
LVLU Lulu's Fashion Lounge - 06/10/22 BofA
- Lulu's Fashion Lounge downgraded to Neutral from Buy at BofA
- 01/14/22 Jefferies
- Jefferies still believes in strength of Lulu's model after management meetings
- 12/06/21 Cowen
- Cowen starts Lulu's Fashion Lounge with Outperform, affordable luxury brand
- 12/06/21 Baird
- Baird starts Lulu's Fashion Lounge with Outperform, sees attractive value
- 05/11/22 Oppenheimer
- Lemonade price target lowered to $30 from $45 at Oppenheimer
- 05/11/22 JMP Securities
- Lemonade price target lowered to $40 from $95 at JMP Securities
- 02/25/22 Barclays
- Lemonade price target lowered to $22 from $43 at Barclays
- 02/25/22 Oppenheimer
- Lemonade price target lowered to $45 from $85 at Oppenheimer
- 05/12/22
- Xponential Fitness backs FY22 revenue $201M-$211M, consensus $209.85M
- 05/12/22
- Xponential Fitness reports Q1 adjusted EPS (19c), consensus 12c
- 03/03/22
- Xponential Fitness sees FY22 revenue $201M-$211M, consensus $199.54M
- 03/03/22
- Xponential Fitness reports Q4 adjusted EPS (21c), consensus (14c)
- 05/23/22
- Transcat sees FY22 adjusted EPS $2.03, consensus $1.72
- 02/01/22
- Transcat reports Q3 EPS 21c, consensus 25c
- 04/25/22
- TrueBlue reports Q1 adjusted EPS 44c, consensus 35c
- 02/02/22
- TrueBlue reports Q4 adjusted EPS 69c, consensus 43c
- 05/04/22
- Skillz sees FY22 revenue view $400M, consensus $399.24M
- 05/04/22
- Skillz reports Q1 EPS (37c), consensus (18c)
- 02/23/22
- Skillz sees FY22 revenue $400M, consensus $548.8M
- 02/23/22
- Skillz reports Q4 EPS (25c), consensus (15c)
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 05/16/22
- Splash Beverage reports Q1 revenue $4.1M vs $2.2M last year
LVLU Lulu's Fashion Lounge - 05/17/22
- Lulu's Fashion Lounge sees FY22 revenue $490M-$500M, consensus $486.92M
- 05/17/22
- Lulu's Fashion Lounge reports Q1 EPS 5c, consensus 5c
- 04/01/22
- Lulu's Fashion Lounge sees FY22 revenue of $480M-$490M, consensus $472.06M
- 03/31/22
- Lulu's Fashion Lounge reports Q4 EPS (3c), consensus (7c)
- 04/05/22
- Landec sees FY22 revenue $179M-$185M , consensus $182,01M
- 04/05/22
- Landec reports Q3 EPS (8c), consensus 0c
- 01/05/22
- Landec reports Q2 EPS ($1.30), consensus (7c)
- 05/09/22
- Lemonade sees FY22 revenue $205M-$208M, consensus $216.49M
- 05/09/22
- Lemonade sees Q2 revenue $46M-48M, consensus $51.83M
- 05/09/22
- Lemonade reports Q1 EPS ($1.21), consensus ($1.43)
- 05/09/22
- Notable companies reporting after market close
- 05/04/22
- Digi International sees Q3 EPS 37c-40c, consensus 37c
- 05/04/22
- Digi International reports Q2 EPS 41c, consensus 32c
- 02/02/22
- Digi International sees Q2 adjusted EPS 33c-37c, consensus 32c
- 02/02/22
- Digi International reports Q1 adjusted EPS 36c, consensus 29c
- 05/05/22
- Denbury reports Q1 adjusted EPS $1.69, consensus $1.53
- 02/24/22
- Denbury reports Q4 adjusted EPS 76c, consensus 70c
- 04/27/22
- Check Point backs FY22 EPS view $6.90-$7.50, consensus $7.25
- 04/27/22
- Check Point sees Q2 adjusted EPS $1.55-$1.65, consensus $1.65
- 04/27/22
- Check Point reports Q1 EPS $1.57, consensus $1.54
- 02/03/22
- Check Point sees FY22 EPS $6.90-$7.50, consensus $7.34
- 04/07/22
- Check-Cap reports Q4 EPS (8c), consensus (3c)
- 05/04/22
- CDW reports Q1 EPS $2.20, consensus $2.01
- 02/09/22
- CDW reports Q4 EPS $2.08, consensus $1.93
- 05/04/22
- CMC Materials sees Q3 revenue flat from Q2, consensus $317.4M
- 05/04/22
- CMC Materials reports Q2 EPS $1.94, consensus $1.81
- 02/02/22
- CMC Materials reports Q1 adjusted EPS $2.06, consensus $1.77
- 05/11/22
- Biodesix still sees 2022 revenue $37.5M-$39.5M, consensus $38.41M
- 05/11/22
- Biodesix reports Q1 EPS (50c), consensus (40c)
- 03/14/22
- Biodesix sees FY22 revenue $37.5M-$39.5M, consensus $35.5M
- 03/14/22
- Biodesix reports Q4 EPS (49c), consensus (49c)
- 04/20/22
- Banner Corp. reports Q1 EPS $1.27, consensus $1.09
- 05/10/22
- Absolute Software ups FY22 revenue view to $209.5M-$210.5M, consensus $207.35M
- 05/10/22
- Absolute Software reports Q3 EPS (13c), consensus (10c)
- 02/08/22
- Absolute Software raises FY22 revenue view to $206M-$208M, consensus $206.04M
- 02/08/22
- Absolute Software reports Q2 EPS (10c), consensus (8c)
|
Conference/Events
|
Consumer Conference to be… Consumer Conference to be held in Nantucket, MA on June 20-22. ShowHide Related Items >><< - 05/10/22
- Xponential Fitness in franchise pact in Mexico for three brands
- 04/21/22
- Xponential Fitness enters collaboration with Lululemon, MIRROR
- 04/05/22
- Xponential Fitness falls -8.5%
- 04/05/22
- Xponential Fitness falls -8.2%
- 05/23/22
- Transcat 'well positioned for profitable growth' in FY23, beyond
- 02/01/22
- Transcat sees Q4 Service revenue growth in high teens
- 01/03/22
- Transcat buys privately-held Tangent Labs for $9M
- 02/10/22
- Tucows approves $40M stock buyback program
- 01/07/22
- Ting Internet to be initial anchor tenant of Colorado Spring Utilities' network
- 06/15/22
- TrueBlue's Cooper: Beharelle's resignation in the best interests of the company
- 06/15/22
- TrueBlue names Chairman Steven Cooper as CEO
- 06/15/22
- TrueBlue announces resignation of CEO Patrick Beharelle, effective June 14
- 06/15/22
- TrueBlue investigation found Beharelle's behaviors violated code of conduct
- 03/23/22
- Skillz announces multiyear partnership with UFC
- 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 03/21/22
- Scholastic appoints Cristina Juvier as CPO
- 05/24/22
- Splash Beverage signs distribution agreement with Buck Distributing
- 05/04/22
- Splash Beverage's TapouT to be offered in Bashas' Family of Stores
- 04/27/22
- Splash Beverage extends distribution into upper midwest
- 04/19/22
- Splash Beverage appoints Ron Wall as CFO
- 06/02/22
- Landec completes $3.2M Curation Foods sale
- 05/10/22
- Lemonade trading resumes
- 05/10/22
- Lemonade trading halted, volatility trading pause
- 05/09/22
- Lemonade up 4% after Q1 reports
- 02/01/22
- Metromile shareholders approve merger agreement with Lemonade
- 05/19/22
- EBET announces agreement with Captain Up
- 05/04/22
- Esports Technologies changes name to EBET
- 04/19/22
- Esports Technologies announces agreement with Incentive Games
- 02/23/22
- Esports Technologies files quantum computing patent
- 05/31/22
- Nasdaq confirms continued listing of Eargo stock
- 05/13/22
- Eargo receives Nasdaq non-compliance letter
- 04/29/22
- Eargo sees Q1 gross systems shipped 5,770
- 04/29/22
- Eargo enters civil settlement agreement with U.S. DOJ
- 05/18/22
- Denbury, Nutrien enter agreement for transportation and storage of CO2
- 05/05/22
- Denbury backs previous 2022 production guidance
- 05/05/22
- Denbury announces $250M share repurchase program
- 03/16/22
- Denbury announces new agreements in Louisiana's industrial corridor
- 05/17/22
- Check Point to partner with Provision-ISR
- 04/27/22
- Check Point CFO 'hopes' supply chain constraints are temporary
- 04/05/22
- Pax8, Check Point enter agreement for cloud-based email security solutions
- 03/02/22
- Check Point launches unified go-to-market organization
- 05/11/22
- Check-Cap initiates trial of C-Scan at Mayo Clinic in Rochester Minnesota
- 02/07/22
- Check-Cap announces FDA approval of amended IDE application for C-Scan study
- 12/23/21
- Check-Cap receives Nasdaq minimum bid price notification
- 06/10/22
- CDW announces addition of two new strategy, marketing executives
- 05/02/22
- TricorBraun appoints Scott Beamer as CFO
- 04/08/22
- Entegris COO Todd Edlund to retire from the company
- 03/03/22
- CMC Materials shareholders approve merger with Entegris
- 02/15/22
- CMC Materials reports 'favorable' conclusion in patent dispute with DuPont
- 06/09/22
- Best Inc. regains NYSE compliance
- 05/10/22
- Best Inc. announces plans to implement ADS ratio change
- 04/21/22
- Li Auto, KE Holdings among new additions to SEC HFCAA provisional list
- 01/18/22
- Best Inc. receives noncompliance notification from NYSE
- 06/07/22
- Biodesix obtains Medicare coverage for Nodify CDT lung nodule test
- 06/03/22
- Biodesix announces research agreement with top U.S. cancer center
- 04/11/22
- Biodesix director Strobeck buys $1M in company shares
- 03/29/22
- Biodesix announces publication of data from GeneStrat NGS test studies
- 05/19/22
- Banner Corp. says shareholders approved all proposals at annual meeting
- 03/04/22
- Banner Corp. announces Copeland, Walsh appointed to board of directors
- 12/22/21
- Banner announces 1.7M share repurchase agreement, 5% of its common stock
- 06/06/22
- Absolute Software announces new partnerships with ISVs 'leveraging' APaaS
- 03/07/22
- Absolute Software CFO Steven Gatoff departs, Ron Fior named interim CFO
- 05/11/22 BMO Capital
- Absolute Software price target lowered to C$12 from C$14 at BMO Capital
- 05/11/22 Canaccord
- Absolute Software price target lowered to $17 from $22 at Canaccord
- 02/09/22 BMO Capital
- Absolute Software price target lowered to C$14 from C$18.50 at BMO Capital
- 02/09/22 TD Securities
- TD Securities upgrades Absolute Software to Buy after 'another' beat and raise
- 06/17/22 Stephens
- Stephens upgrades Banner to Overweight as Street mismodels rate sensitivity
- 06/17/22 Stephens
- Banner Corp. upgraded to Overweight from Equal Weight at Stephens
- 01/24/22 Raymond James
- Banner Corp. price target raised to $72 from $68 at Raymond James
- 09/07/21 DA Davidson
- Banner Corp. downgraded to Neutral from Buy at DA Davidson
- 05/05/22 Evercore ISI
- CDW removed from 'TAP Outperform' list at Evercore ISI
- 04/18/22 Evercore ISI
- CDW added to 'TAP Outperform' list at Evercore ISI
- 04/14/22 Stifel
- CDW upgraded to Buy at Stifel following recent pullback
- 04/14/22 Stifel
- CDW upgraded to Buy from Hold at Stifel
- 06/01/22 Stephens
- Digi International initiated with an Overweight at Stephens
- 02/03/22 Canaccord
- Digi International price target raised to $30 from $28 at Canaccord
- 11/11/21 Roth Capital
- Digi International price target raised to $33 from $28 at Roth Capital
- 11/11/21 Canaccord
- Digi International price target raised to $28 from $25 at Canaccord
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 06/13/22 Jefferies
- Jefferies names five top picks in lifestyle and growth platforms
- 03/14/22 Evercore ISI
- Evercore ISI starts Xponential Fitness at Outperform with $34 price target
- 03/14/22 Evercore ISI
- Xponential Fitness initiated with an Outperform at Evercore ISI
- 03/14/22 Baird
- Xponential Fitness price target raised to $28 from $26 at Baird
- 04/07/22 CL King
- CMC Materials downgraded to Neutral from Buy at CL King
- 04/07/22 CL King
- CMC Materials downgraded to Neutral from Buy at CL King
- 02/04/22 Mizuho
- CMC Materials downgraded to Neutral from Buy at Mizuho
- 12/17/21 Citi
- CMC Materials upgraded to Neutral after buyout at Citi
- 05/24/22 Citi
- California Resources, Denbury may be takeout targets, says Citi
- 05/10/22 Citi
- Denbury initiated with a Buy at Citi
- 05/05/22 Stifel
- Denbury price target raised to $129 from $126 at Stifel
- 04/26/22 KeyBanc
- KeyBanc says Axios report positive for Plug Power, other fuel cell names
- 04/06/22 Barrington
- Landec downgraded to Market Perform from Outperform at Barrington
- 09/30/21 Barrington
- Landec price target lowered to $12 from $14 at Barrington
- 05/23/22 Citi
- Skillz downgraded to Neutral from Buy at Citi
- 03/01/22 Citi
- Skillz price target lowered to $5 from $9 at Citi
- 02/24/22 Stifel
- Skillz price target lowered to $3.50 from $16 at Stifel
- 02/24/22 Wedbush
- Skillz price target lowered to $7.50 from $25 at Wedbush
- 06/02/22 H.C. Wainwright
- Transcat price target lowered to $85 from $105 at H.C. Wainwright
- 05/26/22 Roth Capital
- Transcat price target lowered to $80 from $97 at Roth Capital
- 05/25/22 Craig-Hallum
- Transcat price target lowered to $81 from $94 at Craig-Hallum
- 02/03/22 Craig-Hallum
- Pullback in Transcat shares creates buying opportunity, says Craig-Hallum
- 05/26/22 BMO Capital
- TrueBlue downgraded to Market Perform from Outperform at BMO Capital
- 04/11/22 Sidoti
- TrueBlue reinstated with a Buy at Sidoti
- 10/26/21 Baird
- TrueBlue price target raised to $35 from $31 at Baird
- 04/25/22 EF Hutton
- Splash Beverage initiated with a Buy at EF Hutton
- 02/07/22 Needham
- Needham starts Esports Technologies at Buy on esports betting opportunity
- 02/07/22 Needham
- Esports Technologies initiated with a Buy at Needham
- 06/13/22 Canaccord
- Biodesix's Medicare coverage a meaningful milestone, says Canaccord
- 05/12/22 Canaccord
- Biodesix price target lowered to $7 from $10 at Canaccord
- 04/20/22 Cowen
- Biodesix initiated with an Outperform at Cowen
- 04/18/22 BTIG
- Biodesix price target lowered to $10 from $17 at BTIG
- 05/23/22 Jefferies
- Check Point price target lowered to $130 from $145 at Jefferies
- 04/28/22 Barclays
- Check Point price target lowered to $145 from $160 at Barclays
- 04/28/22 Credit Suisse
- Check Point price target raised to $115 from $105 at Credit Suisse
- 04/28/22 Wells Fargo
- Check Point price target lowered to $130 from $144 at Wells Fargo
- 02/07/22
- Check-Cap upgraded to Buy from Neutral at Dawson James
- 09/23/21
- Fly Intel: Top five analyst downgrades
- 09/23/21 William Blair
- William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
- 09/23/21 Wells Fargo
- Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
- 09/23/21 William Blair
- Eargo downgraded to Market Perform from Outperform at William Blair
LVLU Lulu's Fashion Lounge - 06/10/22 BofA
- Lulu's Fashion Lounge downgraded to Neutral from Buy at BofA
- 01/14/22 Jefferies
- Jefferies still believes in strength of Lulu's model after management meetings
- 12/06/21 Cowen
- Cowen starts Lulu's Fashion Lounge with Outperform, affordable luxury brand
- 12/06/21 Baird
- Baird starts Lulu's Fashion Lounge with Outperform, sees attractive value
- 05/11/22 Oppenheimer
- Lemonade price target lowered to $30 from $45 at Oppenheimer
- 05/11/22 JMP Securities
- Lemonade price target lowered to $40 from $95 at JMP Securities
- 02/25/22 Barclays
- Lemonade price target lowered to $22 from $43 at Barclays
- 02/25/22 Oppenheimer
- Lemonade price target lowered to $45 from $85 at Oppenheimer
- 05/12/22
- Xponential Fitness backs FY22 revenue $201M-$211M, consensus $209.85M
- 05/12/22
- Xponential Fitness reports Q1 adjusted EPS (19c), consensus 12c
- 03/03/22
- Xponential Fitness sees FY22 revenue $201M-$211M, consensus $199.54M
- 03/03/22
- Xponential Fitness reports Q4 adjusted EPS (21c), consensus (14c)
- 05/23/22
- Transcat sees FY22 adjusted EPS $2.03, consensus $1.72
- 02/01/22
- Transcat reports Q3 EPS 21c, consensus 25c
- 04/25/22
- TrueBlue reports Q1 adjusted EPS 44c, consensus 35c
- 02/02/22
- TrueBlue reports Q4 adjusted EPS 69c, consensus 43c
- 05/04/22
- Skillz sees FY22 revenue view $400M, consensus $399.24M
- 05/04/22
- Skillz reports Q1 EPS (37c), consensus (18c)
- 02/23/22
- Skillz sees FY22 revenue $400M, consensus $548.8M
- 02/23/22
- Skillz reports Q4 EPS (25c), consensus (15c)
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 05/16/22
- Splash Beverage reports Q1 revenue $4.1M vs $2.2M last year
LVLU Lulu's Fashion Lounge - 05/17/22
- Lulu's Fashion Lounge sees FY22 revenue $490M-$500M, consensus $486.92M
- 05/17/22
- Lulu's Fashion Lounge reports Q1 EPS 5c, consensus 5c
- 04/01/22
- Lulu's Fashion Lounge sees FY22 revenue of $480M-$490M, consensus $472.06M
- 03/31/22
- Lulu's Fashion Lounge reports Q4 EPS (3c), consensus (7c)
- 04/05/22
- Landec sees FY22 revenue $179M-$185M , consensus $182,01M
- 04/05/22
- Landec reports Q3 EPS (8c), consensus 0c
- 01/05/22
- Landec reports Q2 EPS ($1.30), consensus (7c)
- 05/09/22
- Lemonade sees FY22 revenue $205M-$208M, consensus $216.49M
- 05/09/22
- Lemonade sees Q2 revenue $46M-48M, consensus $51.83M
- 05/09/22
- Lemonade reports Q1 EPS ($1.21), consensus ($1.43)
- 05/09/22
- Notable companies reporting after market close
- 05/04/22
- Digi International sees Q3 EPS 37c-40c, consensus 37c
- 05/04/22
- Digi International reports Q2 EPS 41c, consensus 32c
- 02/02/22
- Digi International sees Q2 adjusted EPS 33c-37c, consensus 32c
- 02/02/22
- Digi International reports Q1 adjusted EPS 36c, consensus 29c
- 05/05/22
- Denbury reports Q1 adjusted EPS $1.69, consensus $1.53
- 02/24/22
- Denbury reports Q4 adjusted EPS 76c, consensus 70c
- 04/27/22
- Check Point backs FY22 EPS view $6.90-$7.50, consensus $7.25
- 04/27/22
- Check Point sees Q2 adjusted EPS $1.55-$1.65, consensus $1.65
- 04/27/22
- Check Point reports Q1 EPS $1.57, consensus $1.54
- 02/03/22
- Check Point sees FY22 EPS $6.90-$7.50, consensus $7.34
- 04/07/22
- Check-Cap reports Q4 EPS (8c), consensus (3c)
- 05/04/22
- CDW reports Q1 EPS $2.20, consensus $2.01
- 02/09/22
- CDW reports Q4 EPS $2.08, consensus $1.93
- 05/04/22
- CMC Materials sees Q3 revenue flat from Q2, consensus $317.4M
- 05/04/22
- CMC Materials reports Q2 EPS $1.94, consensus $1.81
- 02/02/22
- CMC Materials reports Q1 adjusted EPS $2.06, consensus $1.77
- 05/11/22
- Biodesix still sees 2022 revenue $37.5M-$39.5M, consensus $38.41M
- 05/11/22
- Biodesix reports Q1 EPS (50c), consensus (40c)
- 03/14/22
- Biodesix sees FY22 revenue $37.5M-$39.5M, consensus $35.5M
- 03/14/22
- Biodesix reports Q4 EPS (49c), consensus (49c)
- 04/20/22
- Banner Corp. reports Q1 EPS $1.27, consensus $1.09
- 05/10/22
- Absolute Software ups FY22 revenue view to $209.5M-$210.5M, consensus $207.35M
- 05/10/22
- Absolute Software reports Q3 EPS (13c), consensus (10c)
- 02/08/22
- Absolute Software raises FY22 revenue view to $206M-$208M, consensus $206.04M
- 02/08/22
- Absolute Software reports Q2 EPS (10c), consensus (8c)
|
On The Fly
| ShowHide Related Items >><< - 04/29/22
- Cathie Wood sees Teladoc as similar to Amazon.com
- 04/29/22
- Cathie Wood sees potential '10-fold increase' in Teladoc shares
- 04/29/22
- Cathie Wood calls Teladoc 'category killer' over next 5-10 years
- 04/29/22
- Cathie Wood says Teladoc story 'huge,' story is business-to-business
- 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 06/15/22
- Silk Road Medical announces post approval study for TCAR
- 06/02/22
- Silk Road Medical announces expanded Medicare coverage for TCAR
- 05/31/22
- Silk Road Medical secures up to $250M in debt financing
- 05/02/22
- Silk Road Medical gets FDA approval for expanded indications for ENROUTE system
- 06/15/22
- Proterra announces appointment of Hauser to board of directors
- 05/25/22
- Proterra announces Canada's BC Transit approved $20M contract
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 04/19/22
- Proterra appoints Julian Soell as president of Proterra Transit
- 06/16/22
- Oatly Group announce results of 2022 Annual General Meeting
- 06/09/22
- Oatly introduces electric heavy duty trucks to fleet in North America
- 05/25/22
- Oatly Group launches one-hour delivery in Los Angeles, New York City
- 04/21/22
- Oatly Group names Jean-Cristophe Flatin as president, Daniel Ordonez as COO
- 05/16/22
- Tiger Global buys Starry, exits Adobe in Q1
- 03/28/22
- Cathie Wood's ARK Investment bought 43.6K shares of Monday.com today
- 03/02/22
- Monday.com announces strategic alliance with KPMG
- 05/05/22
- Bilibili provides update on status under HFCAA
- 05/02/22
- Bilibili provides update on voluntary conversion to dual-primary listing
- 03/03/22
- Bilibili announces $500M share repurchase program, CEO to purchase $10M shares
- 06/10/22
- KE Holdings rises 6.3%
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 05/04/22
- KE Holdings announces proposed dual primary listing on SEHK
- 04/21/22
- Li Auto, KE Holdings among new additions to SEC HFCAA provisional list
- 05/26/22 Oppenheimer
- Oppenheimer continues to favor Teladoc, new policies positive for telehealth
- 05/13/22 Piper Sandler
- Teladoc price target raised to $42 from $21 at Piper Sandler
- 05/05/22 Argus
- Teladoc cut to Hold at Argus after 'disappointing' Q1 amid increased competition
- 05/05/22 Argus
- Teladoc downgraded to Hold from Buy at Argus
- 06/14/22 Credit Suisse
- Oatly Group price target lowered to $7 from $8 at Credit Suisse
- 05/05/22 Citi
- Oatly Group price target lowered to $10 from $11 at Citi
- 05/05/22 Piper Sandler
- Oatly Group valuation 'very compelling,' says Piper Sandler
- 05/03/22 Mizuho
- Oatly Group price target lowered to $4 from $6 at Mizuho
- 06/01/22 Tigress Financial
- Monday.com price target lowered to $240 from $432 at Tigress Financial
- 05/17/22 Cowen
- Monday.com price target lowered to $200 from $240 at Cowen
- 05/17/22 Canaccord
- Monday.com price target lowered to $150 from $200 at Canaccord
- 02/24/22 Needham
- Monday.com price target lowered to $230 from $420 at Needham
- 06/12/22 Goldman Sachs
- KE Holdings price target raised to $23 from $21.70 at Goldman Sachs
- 05/16/22 JPMorgan
- KE Holdings upgraded to Neutral from Underweight at JPMorgan
- 04/18/22 UBS
- KE Holdings upgraded to Buy from Neutral at UBS
- 04/10/22 Goldman Sachs
- KE Holdings assumed with a Buy at Goldman Sachs
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 06/01/22 DA Davidson
- Proterra initiated with a Buy at DA Davidson
- 05/19/22 Barclays
- Proterra price target lowered to $6 from $8 at Barclays
- 05/16/22 Citi
- Proterra price target lowered to $6.50 from $8.50 at Citi
- 05/13/22 BofA
- Proterra double downgraded to Underperform at BofA
- 05/31/22 Piper Sandler
- Piper says Silk Road in 'much stronger' position after debt financing pact
- 05/17/22 Citi
- Silk Road Medical price target lowered to $33 from $44 at Citi
- 04/05/22 Wolfe Research
- Silk Road Medical initiated with an Outperform at Wolfe Research
- 04/04/22 Piper Sandler
- Silk Road Medical price target raised to $43 from $38 at Piper Sandler
- 06/13/22 JPMorgan
- Bilibili price target raised to $25 from $19 at JPMorgan
- 06/10/22 Citi
- Bilibili price target lowered to $45 from $46 at Citi
- 06/10/22 Barclays
- Bilibili price target raised to $26 from $24 at Barclays
- 06/10/22 ICBC
- Bilibili downgraded to Neutral from Outperform at ICBC
- 04/27/22
- Teladoc sees FY22 EPS ($43.50)-($43.00), consensus ($1.53)
- 04/27/22
- Teladoc reports Q1 EPS ($41.58) vs ($1.31) year over year
- 04/27/22
- Notable companies reporting after market close
- 02/22/22
- Teladoc sees FY22 EPS ($1.60)-($1.40), consensus ($1.78)
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 05/04/22
- Silk Road Medical sees FY22 revenue $127M-$132M, consensus $129.54M
- 05/04/22
- Silk Road Medical reports Q1 EPS , consensus (37c)
- 03/01/22
- Proterra reports Q4 EPS (43c), consensus (16c)
- 05/04/22
- Oatly Group reaffirms FY22 revenue view $880M-$920M, consensus $890.15M
- 05/04/22
- Oatly Group reports Q1 EPS (15c), consensus (12c)
- 03/09/22
- Oatly Group sees 2022 revenue $880M-$920M, consensus $1.01B
- 03/09/22
- Oatly Group reports Q4 EPS (13c), consensus (9c)
- 05/16/22
- Monday.com raises FY22 revenue view to $488M-$492M from $470M-$475M
- 05/16/22
- Monday.com sees Q2 revenue $117M-$119M, consensus $110.88M
- 05/16/22
- Monday.com reports Q1 EPS (96c), consensus ($1.02)
- 02/23/22
- Monday.com sees FY22 revenue $470M-$475M, consensus $443.1M
- 06/09/22
- Bilibili sees Q2 revenue RMB4.85B-RMB4.95B from RMB5.05B in Q1
- 06/09/22
- Bilibili reports Q1 adjusted EPS (66c), consensus (62c)
- 06/08/22
- Notable companies reporting before tomorrow's open
- 03/03/22
- Bilibili sees Q1 revenue RMB 5.3B-RMB 5.5B
- 05/31/22
- KE Holdings sees Q2 revenue $1.6B-$1.7B, consensus $2.65B
- 05/31/22
- KE Holdings reports Q1 adjusted EPS 0c, consensus (5c)
- 03/09/22
- KE Holdings sees Q1 revenue $1.8B-$2B, consensus $1.98B
- 03/09/22
- KE Holdings reports Q4 adjusted earnings per ADS 1c, consensus (7c)
- 05/07/22
- Disrupters getting punished, old-school rivals the winners, Barron's says
- 03/08/22
- Lawmakers considering extending telehealth policies, STATNews reports
- 01/08/22
- Proterra looking like a bargain, Barron's says
- 05/24/22
- Oatly Group lining up eventual CEO successor to Toni Petersson, WSJ reports
- 05/03/22
- Spruce Point says covered remaining Oatly position
- 12/30/21
- Two-thirds of 2021 IPOs now trading below offer prices, WSJ reports
- 03/16/22
- Chinese stocks jump as Beijing vows to keep markets stable, Reuters reports
- 05/05/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/28/22
- What You Missed On Wall Street On Thursday
- 04/28/22
- What You Missed On Wall Street This Morning
- 04/28/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/27/22
- Sell these stocks now, proven algorithm says
- 05/13/22
- Proven algorithm says sell these stocks now
- 02/23/22
- What You Missed On Wall Street On Wednesday
- 02/23/22
- What You Missed On Wall Street This Morning
- 06/06/22
- What You Missed This Week in EVs and Clean Energy
- 05/16/22
- What You Missed This Week in EVs and Clean Energy
- 05/13/22
- What You Missed On Wall Street On Friday
- 05/13/22
- What You Missed On Wall Street This Morning
- 05/24/22
- What You Missed On Wall Street On Tuesday
- 05/04/22
- What You Missed On Wall Street On Wednesday
- 05/04/22
- What You Missed On Wall Street This Morning
- 04/06/22
- What You Missed On Wall Street On Wednesday
- 05/16/22
- What You Missed On Wall Street On Monday
- 05/16/22
- What You Missed On Wall Street This Morning
- 05/16/22
- Fly Intel: Pre-market Movers
- 06/12/22
- Sell these stocks now, proven algorithm says
- 06/09/22
- What You Missed On Wall Street On Thursday
- 06/09/22
- What You Missed On Wall Street This Morning
- 06/09/22
- Fly Intel: Pre-market Movers
- 06/03/22
- Sell these stocks now, proven algorithm says
- 05/31/22
- What You Missed On Wall Street On Tuesday
- 05/31/22
- What You Missed On Wall Street This Morning
- 05/31/22
- Fly Intel: Pre-market Movers
- 05/03/22
- Unusually active option classes on open May 3rd
- 05/02/22
- Teladoc call volume above normal and directionally bullish
- 04/27/22
- Teladoc options imply 12.3% move in share price post-earnings
- 04/25/22
- Teladoc call volume above normal and directionally bullish
- 02/15/22
- Beauth Health Company call buyer realizes 50% same-day gains
- 01/28/22
- Beauth Health Company put volume heavy and directionally bearish
- 05/27/22
- Unusually active option classes on open May 27th
- 03/11/22
- Oatly Group AB put volume heavy and directionally bearish
- 02/15/22
- Oatly Group AB call volume above normal and directionally bullish
- 02/11/22
- Oatly Group AB call volume above normal and directionally bullish
- 06/08/22
- Unusually active option classes on open June 8th
- 06/07/22
- Bilibili call volume above normal and directionally bullish
- 06/03/22
- Bilibili put volume heavy and directionally bearish
- 04/04/22
- Bilibili call volume above normal and directionally bullish
- 06/14/22
- Unusually active option classes on open June 14th
- 05/18/22
- KE Holdings options imply 7.2% move in share price post-earnings
- 05/11/22
- KE Holdings options imply 10.6% move in share price post-earnings
- 04/04/22
- KE Holdings call volume above normal and directionally bullish
|
Over a month ago |
On The Fly
| ShowHide Related Items >><< - 05/05/22
- Wayfair falls -19.3%
- 05/05/22
- Wayfair falls -20.0%
- 05/05/22
- Wayfair falls -17.9%
- 05/05/22
- Wayfair says expects revenue growth to accelerate as year goes on
- 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
- 05/17/22
- On Holding rises 15.0%
- 03/18/22
- On Holding rises 9.4%
- 03/18/22
- On Holding rises 7.2%
- 04/25/22
- NexGen Energy signs IBA with Clearwater River Dene Nation for Rook I Project
- 03/01/22
- NexGen Energy uplists to NYSE from NYSE American
- 05/03/22
- MicroStrategy names Andrew Kang CFO
- 04/05/22
- MicroStrategy acquired 4,167 bitcoins for $190.5M in cash
- 03/29/22
- MicroStrategy borrows $205M from Silvergate to buy more bitcoin
- 03/09/22
- Biden to sign executive order on 'responsible innovation' in digital assets
- 05/13/22
- Lightspeed rises 26.8%
- 05/13/22
- Lightspeed rises 18.1%
- 03/24/22
- Lightspeed names Brandon Nussey as COO, Asha Bakshani as CFO
- 02/07/22
- Lightspeed announces direct selling, advertising on TikTok via Ecwid
- 04/28/22
- Krystal Biotech's Jeune Aesthetics announces formation of SAB
- 04/11/22
- Krystal Biotech announces home dosing in B-VEC open label extension study
- 03/28/22
- Krystal Biotech announces publication of Phase 1, 2 trial data of B-VEC
- 03/22/22
- Jeune Aesthetics announces clinical Phase 1 efficacy data for KB301
- 05/16/22
- Kornit Digital highlights Kornit Fashion Week London
- 05/11/22
- Kornit Digital sees revenue stronger in Q3, Q4 vs. Q2
- 01/26/22
- Kornit Digital announces opening of new ink manufacturing facility
- 01/25/22
- Kornit Digital enters definitive agreement to acquire Tesoma
IRT Independence Realty Trust - 05/19/22
- Independence Realty Trust to replace Mimecast in S&P 400 at open on 5/19
- 05/18/22
- Independence Realty Trust announces $250M stock buyback, boosts dividend 17%
- 12/21/21
- Independence Realty Trust falls -4.1%
- 05/12/22
- Core Scientific sees FY22 total hashrate 30-32 EH/s
- 05/05/22
- Core Scientific produced 1,121 bitcoins for its own account in April
- 04/05/22
- Core Scientific appoints Denise Sterling CFO, has 80K bitcoin miners as of March
- 04/05/22
- Core Scientific announces self-mined 1,143 bitcoins in March
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 04/20/22
- Confluent holder buys $5.1M in common stock
- 03/31/22
- Confluent appoints Gunjan Aggarwal as Chief People Officer
- 02/14/22
- Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms
- 04/05/22
- ACV launches Carrier by ACV Transportation app
- 02/28/22
- ACV Auctions acquires Monk SAS, terms not disclosed
- 12/02/21
- ACV Auctions director sells $2.15M in common stock
- 05/23/22 Bernstein
- Wayfair initiated with an Underperform at Bernstein
- 05/10/22 Truist
- Wayfair price target lowered to $130 from $190 at Truist
- 05/06/22 Cowen
- Wayfair price target lowered to $140 from $220 at Cowen
- 05/06/22 Credit Suisse
- Wayfair price target lowered to $195 from $256 at Credit Suisse
- 05/23/22 Jefferies
- MicroStrategy price target lowered to $215 from $225 at Jefferies
- 05/16/22 Jefferies
- MicroStrategy does not face liquidity, solvency risk, says Jefferies
- 05/13/22 William Blair
- MicroStrategy can 'comfortably' support interest payments, says William Blair
- 05/04/22 Canaccord
- MicroStrategy price target lowered to $453 from $540 at Canaccord
- 05/18/22 Wells Fargo
- Confluent price target lowered to $35 from $45 at Wells Fargo
- 05/06/22 Credit Suisse
- Confluent price target lowered to $80 from $100 at Credit Suisse
- 05/06/22 Deutsche Bank
- Confluent price target lowered to $28 from $63 at Deutsche Bank
- 04/19/22 Barclays
- Confluent price target lowered to $44 from $71 at Barclays
- 03/17/22 B. Riley
- Core Scientific price target raised to $16 from $15 at B. Riley
- 02/24/22 BTIG
- Core Scientific initiated with a Buy at BTIG
- 02/11/22 B. Riley
- B. Riley starts 'diversified' bitcoin miner Core Scientific with Buy
- 02/11/22 B. Riley
- Core Scientific initiated with a Buy at B. Riley
- 03/29/22 Guggenheim
- Krystal Biotech price target lowered to $101 from $114 at Guggenheim
- 02/28/22 H.C. Wainwright
- Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
- 01/18/22 BofA
- Krystal Biotech initiated with a Buy at BofA
- 01/18/22 BofA
- Krystal Biotech initiated with a Buy at BofA
- 05/20/22 TD Securities
- Lightspeed price target lowered to C$60 from C$80 at TD Securities
- 05/20/22 Raymond James
- Lightspeed price target raised to C$43 from C$40 at Raymond James
- 05/20/22 Truist
- Lightspeed price target lowered to $45 from $60 at Truist
- 05/20/22 Raymond James
- Lightspeed removed from Analyst Current Favorites list at Raymond James
- 05/18/22 Baird
- On Holding price target lowered to $35 from $46 at Baird
- 05/18/22 Williams Trading
- On Holding upgraded to Hold from Sell at Williams Trading
- 05/09/22 BofA
- On Holding initiated with an Underperform at BofA
- 04/19/22 Berenberg
- On Holding initiated with a Buy at Berenberg
- 05/18/22 JMP Securities
- ACV Auctions price target lowered to $20 from $32 at JMP Securities
- 05/12/22 Needham
- ACV Auctions price target lowered to $14 from $20 at Needham
- 05/12/22 Canaccord
- ACV Auctions price target lowered to $22 from $25 at Canaccord
- 05/12/22 Truist
- ACV Auctions price target lowered to $18 from $30 at Truist
IRT Independence Realty Trust - 05/10/22 Barclays
- Independence Realty Trust price target lowered to $28 from $30 at Barclays
- 05/09/22 BTIG
- Independence Realty Trust assumed with a Buy at BTIG
- 04/22/22 Jefferies
- Independence Realty Trust initiated with a Buy at Jefferies
- 03/24/22 Deutsche Bank
- Independence Realty Trust price target raised to $30 from $29 at Deutsche Bank
- 05/12/22 Citi
- Kornit Digital selloff an attractive buying opportunity, says Citi
- 04/21/22 Needham
- Kornit Digital price target lowered to $155 from $202 at Needham
- 02/16/22 Citi
- Kornit Digital earnings selloff a buying opportunity, says Citi
- 02/09/22 Craig-Hallum
- Kornit Digital price target lowered to $135 from $180 at Craig-Hallum
- 05/25/22 Raymond James
- NexGen Energy removed from Analyst Current Favorites list at Raymond James
- 04/22/22 Canaccord
- NexGen Energy price target raised to C$10.75 from C$10 at Canaccord
- 04/11/22 RBC Capital
- NexGen Energy upgraded to Outperform from Sector Perform at RBC Capital
- 03/03/22 Raymond James
- NexGen Energy price target raised to C$9 from C$8.50 at Raymond James
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 05/13/22 BMO Capital
- First Majestic price target lowered to C$10.50 from C$12 at BMO Capital
- 05/13/22 TD Securities
- First Majestic price target lowered to C$12 from C$20 at TD Securities
- 04/20/22 National Bank
- First Majestic price target raised to C$18 from C$17 at National Bank
- 04/19/22 BMO Capital
- First Majestic price target lowered to C$12 from C$13 at BMO Capital
- 05/05/22
- Wayfair reports Q1 EPS ($1.96), consensus ($1.56)
- 05/05/22
- Wayfair reports Q1 EPS ($1.96), consensus ($1.56)
- 05/04/22
- Notable companies reporting before tomorrow's open
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
- 05/17/22
- On Holding expects FY22 net sales to exceed CHF 1.04B
- 05/17/22
- On Holding reports Q1 net income CHF 14.3M vs CHF (10.5M) last year
- 03/18/22
- On Holding now expects net sales to exceed CHF 990M in FY22
- 03/18/22
- On Holding reports Q4 net loss of CHF (187.0M) vs. CHF (2.6M) last year
- 05/03/22
- MicroStrategy reports Q1 adjusted EPS ($10.42), two estimates $1.41
- 02/01/22
- MicroStrategy reports Q4 EPS ($8.43), consensus $1.49
- 05/20/22
- Lightspeed sees FY23 revenue of $740M-$760M
- 05/20/22
- Lightspeed sees Q1 revenue of $165M-$170M
- 05/20/22
- Lightspeed reports Q4 adjusted EPS (15c) vs. (10c) a year ago
- 02/02/22
- Lightspeed sees FY22 revenue $540M-$544M, up from $520M-$535M
- 02/28/22
- Krystal Biotech reports Q4 EPS (94c), consensus (73c)
- 05/11/22
- Kornit Digital sees Q2 revenue $85M-$95M, consensus $102.04M
- 05/11/22
- Kornit Digital reports Q1 adjusted EPS 0c, consensus 15c
- 02/15/22
- Kornit Digital sees Q1 revenue $87M-$91M, consensus $86.58M
- 02/15/22
- Kornit Digital reports Q4 EPS 13c, consensus 24c
IRT Independence Realty Trust - 05/03/22
- Independence Realty raises FY22 core CCO view to $1.04-$1.06 from $1.00-$1.04
- 05/03/22
- Independence Realty Trust reports Q1 core FFO 25c, consensus 25c
- 02/16/22
- Independence Realty Trust sees FY22 core FFO $1.00-$1.04, consensus 97c
- 02/16/22
- Independence Realty Trust reports Q4 core FFO 24c, consensus 23c
- 05/12/22
- Core Scientific reports Q1 EPS ($1.52), consensus 15c
- 03/29/22
- Core Scientific reports FY21 EPS 32c, consensus 51c
- 05/05/22
- Confluent raises FY22 EPS view to (79c)-(73c) from (82c)-(74c)
- 05/05/22
- Confluent sees Q2 adjusted EPS (21c)-(19c), consensus (20c)
- 05/05/22
- Confluent reports Q1 adjusted EPS (19c), consensus (21c)
- 02/10/22
- Confluent sees FY22 EPS (82c) to (74c), consensus (79c)
- 05/11/22
- ACV Auctions sees FY22 revenue $452M-$460M, consensus $459.08M
- 05/11/22
- ACV Auctions reports Q1 EPS (19c), consensus (16c)
- 02/16/22
- ACV Auctions sees FY22 revenue $450M-460M, consensus $447.66M
- 02/16/22
- ACV Auctions sees Q1 revenue $100M-$102M, consensus $98.27M
|
On The Fly
| ShowHide Related Items >><< - 05/05/22
- Wayfair falls -19.3%
- 05/05/22
- Wayfair falls -20.0%
- 05/05/22
- Wayfair falls -17.9%
- 05/05/22
- Wayfair says expects revenue growth to accelerate as year goes on
- 03/29/22
- TuSimple, Loadsmith partner for SAE L4 autonomous technology
- 03/21/22
- TuSimple to explore certain transactions for Asia-Pacific-focused businesses
- 03/07/22
- Cathie Wood's ARK Investment bought 260K shares of TuSimple today
- 03/03/22
- TuSimple: Xiaodi Hou to succeed Cheng Lu as President and CEO
SWTX SpringsWorks Therapeutics - 04/19/22
- SpringsWorks announces agreeement with Regeneron for nirogacestat
- 12/10/21
- SpringsWorks Therapeutics announces trial collaboration with AbbVie
- 12/06/21
- SpringsWorks Therapeutics doses first patient in Phase 1b/2 nirogacestat study
- 11/29/21
- SpringsWorks Therapeutics announces full enrollment of Phase 2b ReNeu trial
- 05/05/22
- Block jumps 9% to over $104 after reporting Q1 results
- 05/05/22
- Block sees Square GPV up 29% for April
- 05/03/22
- Rite Aid and Block unit Afterpay partner to offer BNPL on everyday items
- 04/29/22
- Jack Dorsey says Twitter needs transparency to 'earn trust'
- 05/11/22
- Beauty Health announces partnership with Jennifer Lopez's JLo Beauty
- 05/09/22
- Beauty Health appoints Amy Juaristi as head of corporate affairs
- 01/20/22
- Beauty Health announces Andrew Stanleick as President and CEO
RSI Rush Street Interactive - 04/04/22
- Rush Street Interactive launches BetRivers online casino, sportsbook in Ontario
- 03/31/22
- Rush Street Interactive receives RG Check iGaming Accreditation from RGC
- 03/22/22
- Rush Street Interactive signs Mike Francesa to brand, content deal
- 03/10/22
- Rush Street Interactive receives iGaming operator registration from AGCO
- 04/28/22
- Krystal Biotech's Jeune Aesthetics announces formation of SAB
- 04/11/22
- Krystal Biotech announces home dosing in B-VEC open label extension study
- 03/28/22
- Krystal Biotech announces publication of Phase 1, 2 trial data of B-VEC
- 03/22/22
- Jeune Aesthetics announces clinical Phase 1 efficacy data for KB301
- 12/17/21
- Freshpet down 12% at $83.75 after cutting FY21 guidance on supply chain issues
- 11/30/21
- Freshpet CEO buys $200K in common stock
- 03/08/22
- Flywire enters strategic partnership with Tribal Group
- 02/08/22
- Flywire partners with Ascensus to digitize 529 college savings plan payments
- 12/15/21
- Flywire acquires WPM to accelerate expansion in the UK market
- 04/11/22
- BRP Group announces Richard Tallo as chief marketing officer
- 03/03/22
- BRP Group to acquire Westwood Insurance Agency
- 01/31/22
- BRP Group promotes Seth Cohen to General Counsel
- 11/22/21
- BRP Group enters into agreement to buy substantially all assetes of WGB
- 05/11/22
- Aurora, Covenant team to find ways to optimize Covenant long-haul operations
- 04/06/22
- Aurora ,Werner launch commercial pilot to autonomously haul freight in Texas
- 04/06/22
- Aurora Innovation opens three new terminals in El Paso, Fort Worth and Houston
- 02/14/22
- Third Point buys Rivian, exits Meta in Q4
- 05/12/22 Mizuho
- Mizuho cuts Block target, says 'must decouple' story from bitcoin
- 05/09/22 Barclays
- Block price target lowered to $150 from $182 at Barclays
- 05/06/22 Truist
- Block price target lowered to $165 from $220 at Truist
- 05/06/22 Cowen
- Block price target lowered to $148 from $188 at Cowen
- 05/10/22 Truist
- Wayfair price target lowered to $130 from $190 at Truist
- 05/06/22 Cowen
- Wayfair price target lowered to $140 from $220 at Cowen
- 05/06/22 Credit Suisse
- Wayfair price target lowered to $195 from $256 at Credit Suisse
- 05/06/22 Canaccord
- Wayfair price target lowered to $120 from $145 at Canaccord
- 05/03/22 Cowen
- Freshpet price target lowered to $163 from $181 at Cowen
- 05/03/22 Oppenheimer
- Freshpet price target lowered to $110 from $120 at Oppenheimer
- 05/03/22 Citi
- Freshpet price target lowered to $72 from $80 at Citi
- 04/28/22 Benchmark
- Benchmark starts pet food 'disruptor' Freshpet at Buy
- 12/15/21 Goldman Sachs
- Aurora Innovation initiated with a Neutral at Goldman Sachs
- 05/11/22 Canaccord
- Beauty Health price target lowered to $22 from $27 at Canaccord
- 05/11/22 DA Davidson
- Beauty Health price target lowered to $24 from $35 at DA Davidson
- 05/11/22 Piper Sandler
- Beauty Health price target lowered to $24 from $26 at Piper Sandler
- 04/28/22 Piper Sandler
- Beauty Health price target lowered to $26 from $31 at Piper Sandler
- 03/29/22 Guggenheim
- Krystal Biotech price target lowered to $101 from $114 at Guggenheim
- 02/28/22 H.C. Wainwright
- Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
- 01/18/22 BofA
- Krystal Biotech initiated with a Buy at BofA
- 01/18/22 BofA
- Krystal Biotech initiated with a Buy at BofA
RSI Rush Street Interactive - 04/27/22 Wells Fargo
- Wells Fargo upgrades Rush Street Interactive to Overweight, lowers target to $10
- 04/27/22 Wells Fargo
- Rush Street upgraded to Overweight from Equal Weight at Wells Fargo
- 03/10/22 Benchmark
- Rush Street Interactive price target lowered to $16 from $27 at Benchmark
- 03/03/22 Oppenheimer
- Rush Street Interactive price target lowered to $11 from $14 at Oppenheimer
SWTX SpringsWorks Therapeutics - 03/01/22 H.C. Wainwright
- SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright
- 10/27/21 Wedbush
- Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
- 09/08/21 JPMorgan
- SpringsWorks price target raised to $105 from $97 at JPMorgan
- 07/21/21 H.C. Wainwright
- SpringsWorks price target raised to $136 from $124 at H.C. Wainwright
- 05/13/22 RBC Capital
- TuSimple downgraded to Sector Perform from Outperform at RBC Capital
- 05/13/22 RBC Capital
- TuSimple downgraded to Sector Perform from Outperform at RBC Capital
- 05/12/22 KeyBanc
- TuSimple price target lowered to $30 from $40 at KeyBanc
- 05/04/22 Baird
- TuSimple price target lowered to $17 from $28 at Baird
- 05/12/22 JPMorgan
- BRP Group selloff on Q1 report overdone, says JPMorgan
- 04/18/22 UBS
- BRP Group initiated with a Buy at UBS
- 03/14/22 BofA
- BRP Group upgraded to Buy from Neutral at BofA
- 03/02/22 Wells Fargo
- BRP Group price target lowered to $39 from $44 at Wells Fargo
- 05/11/22 Wells Fargo
- Flywire price target lowered to $36 from $41 at Wells Fargo
- 05/11/22 Raymond James
- Flywire price target lowered to $33 from $39 at Raymond James
- 04/28/22 Citi
- Citi opens 'Positive Catalyst Watch' on Flywire shares
- 04/12/22 SMBC Nikko
- Flywire initiated with an Outperform at SMBC Nikko
- 05/05/22
- Wayfair reports Q1 EPS ($1.96), consensus ($1.56)
- 05/05/22
- Wayfair reports Q1 EPS ($1.96), consensus ($1.56)
- 05/04/22
- Notable companies reporting before tomorrow's open
- 05/03/22
- TuSimple reports Q1 EPS (50c), consensus (55c)
- 02/10/22
- TuSimple sees FY22 revenue $9M-$11M, consensus $25.46M
- 02/09/22
- TuSimple reports Q4 EPS (53c), consensus (52c)
SWTX SpringsWorks Therapeutics - 05/05/22
- SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02)
- 02/24/22
- SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c)
- 05/05/22
- Block reports Q1 adjusted EPS 18c, consensus 21c
- 05/05/22
- Notable companies reporting after market close
- 02/24/22
- Block reports Q4 adjusted EPS 27c, consensus 22c
- 02/24/22
- Notable companies reporting after market close
- 05/10/22
- Beauty Health raises FY22 revenue view to $330M-$340M from $320M-$330M
- 05/10/22
- Beauty Health reports Q1 EPS (13c), consensus (1c)
- 02/22/22
- Beauty Health sees FY22 revenue $320M-$330M, consensus $314M
- 02/22/22
- Beauty Health reports Q4 EPS (12c), consensus (2c)
RSI Rush Street Interactive - 05/04/22
- Rush Street raises 2022 sales outlook to $600M-$650M from $580M-$530M
- 05/04/22
- Rush Street Interactive reports Q1 EPS (24c), consensus (19c)
- 03/02/22
- Rush Street Interactive sees 2022 revenue $580M-$630M, consensus $611.04M
- 03/02/22
- Rush Street Interactive reports Q4 adjusted EPS (15c), consensus (11c)
- 02/28/22
- Krystal Biotech reports Q4 EPS (94c), consensus (73c)
- 05/02/22
- Freshpet backs FY22 revenue view at least $575M, consensus $576.99M
- 05/02/22
- Freshpet reports Q1 EPS (40c), consensus (39c)
- 02/28/22
- Freshpet sees FY22 revenue $575M, consensus $562.4M
- 02/28/22
- Freshpet reports Q4 EPS (21c), consensus (16c)
- 05/10/22
- Flywire sees Q2 revenue $50M-$53M, consensus $47.26M
- 05/10/22
- Flywire raises FY22 revenue view $269M-$279M from $266M-$276M
- 05/10/22
- Flywire reports Q1 EPS (10c), consensus (3c)
- 03/02/22
- Flywire seesFY22 revenue $266M-$276M, consensus $238.41M
- 05/10/22
- BRP Group reports Q1 adjusted EPS 50c, consensus 52c
- 03/01/22
- BRP Group reports Q4 adjusted EPS 10c, consensus 9c
- 05/04/22
- Aurora Innovation reports Q1 EPS (7c), one estimate (18c)
|